• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Development and validation of PEN-FAST clinical prediction tool for possible penicillin allergy

byJames EnglandandAnees Daud
March 19, 2020
in Infectious Disease, Pediatrics, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In patients with reported history of penicillin allergy, a clinical prediction tool based on timing, character, and severity of the reaction accurately predicted results of further confirmatory allergy testing.

2. Using a score cut-off of 3 points, the PEN-FAST prediction tool had a high negative predictive probability in ruling out true penicillin allergy in both the internal and external validation cohorts.

Evidence Rating Level: 2 (Good)       

Study Rundown: Patient-reported allergies to penicillin are common but often do not reflect true allergies when further investigated with skin-prick or other confirmatory testing. History of penicillin allergy may limit therapeutic options for common bacterial infections and is associated with worse clinical outcomes. Further evaluation with antibiotic allergy testing procedures take time and is costly. The current study sought to develop and validate a clinical prediction tool that could accurately predict results of antibiotic allergy testing and may aid clinicians in predicting patients with low risk of clinically significant penicillin allergy. The study found that a PEN-FAST score, utilizing the clinical severity, need for treatment, skin manifestations, and timing of the reported reaction, was able to predict patients who were low risk of having positive antibiotic allergy test results. These results were consistent in an external validation cohort data set.

The PEN-FAST score is a simple clinical prediction tool that may help clinicians and antimicrobial stewardship programs identify patients with low-risk penicillin allergy histories that may not need confirmatory allergy testing. The strengths of the study include the large number of patients with formal allergy assessment, and the use of geographically separate populations in Australia and the United States. The limitations of the design include the exclusion of non-penicillin beta-lactam reactions, and low numbers of patients with severe cutaneous adverse reactions included in the study.

Click to read the study in JAMA Internal Medicine

Relevant Reading: Designing Predictive Models for Beta-Lactam Allergy Using the Drug Allergy and Hypersensitivity Database

RELATED REPORTS

#VisualAbstract: Donidalorsen reduces attacks in patients with hereditary angioedema

Donidalorsen reduces attacks in patients with C1 inhibitor deficiency

Garadacimab significantly reduces frequency of hereditary angioedema exacerbations

In-Depth [prospective cohort]: This study used data from population cohorts from Melbourne, Sydney, and Perth, Australia, and Nashville, Tennessee. Patients were included if they were 16 years or older, reported a history of penicillin allergy, and underwent subsequent skin, intradermal, and/or oral testing. Patients were excluded if they did not undergo oral penicillin challenge after negative skin/intradermal testing. Backward stepwise logistic regression was used to derive the model. The primary outcome for the model was positive result on penicillin allergy testing.

The model, PEN-FAST, included having the reaction within the last 5 years (2 points), angioedema/anaphylaxis (2 points), severe cutaneous adverse reaction (2 points), and treatment required for the reaction (1 point). For the internal validity cohort, the area under the receiver-operating curve was 0.805. A cutoff score of 3 points lead to a negative predictive value of 96.3% (95% CI, 94.1%-97.8%).

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Anaphylaxisangioedemabeta-lactamcutaneous adverse reactionpenicillinpenicillin allergy
Previous Post

MRI-targeted biopsies alone may underestimate grade of prostate cancer 

Next Post

Variation in blood pressure and long-term risk of dementia: A population-based cohort study

RelatedReports

#VisualAbstract: Donidalorsen reduces attacks in patients with hereditary angioedema
StudyGraphics

#VisualAbstract: Donidalorsen reduces attacks in patients with hereditary angioedema

April 13, 2022
Cardiology

Donidalorsen reduces attacks in patients with C1 inhibitor deficiency

March 22, 2022
Chronic Disease

Garadacimab significantly reduces frequency of hereditary angioedema exacerbations

March 16, 2022
Peripregnancy nut consumption may decrease development of nut allergies
Chronic Disease

Peanut oral immunotherapy desensitizes young children with non-anaphylactic peanut allergies

March 1, 2022
Next Post
Intensive blood pressure control may decrease risk of mild cognitive impairment

Variation in blood pressure and long-term risk of dementia: A population-based cohort study

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Large study describes characteristics of children with COVID-19 in China

Testosterone replacement in male cancer survivors helps improve body composition

Testosterone replacement in male cancer survivors helps improve body composition

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.